"March 9th Biomathematics Symposium: Mathematical Modeling in Biomedicine, The Carol Newton Legacy,
UCLA Neuroscience Research Building (NRB) Auditorium.
For details, see the events section"
Congratulations to Jin Zhou, who successfully defended her doctoral thesis, "Advances in Pedigree Analysis: Hardy-Weinberg Equilibrium, Strain Imputation, and Maternal Effects." Jin is pictured with her doctoral committee, (left to right) Dr. Christina Palmer, Dr. Elliot M. Landaw, Dr. Janet Sinsheimer (co-chair), Jin, and Dr. Ken Lange (co-chair).
Congratulations to alumnus Marc Suchard (Class of 2002) who recently received a Google Research Award to work on problems in massively parallel multinomial logit regression.
Congratulations to Hillary Protas, who successfully defended her doctoral thesis, "Quantitative PET Image Analysis Using MR Derived Cortical Surface Maps in AD Patients and Control Subjects." Her doctoral committee: Dr Henry Huang (chair), Dr. Elliot M. Landaw, Dr. Kenneth Lange, Dr. Jorge Barrio, Dr. Marvin Bergsneider, and Dr. Paul Thompson.
Congratulations to Mary Sehl, M.D. Ph.D., who successfully defended her doctoral thesis, "Stochastic dynamics of Cancer Stem Cells". Her doctoral committee: Dr. Kenneth Lange (co-chair), Dr. Janet Sinsheimer (co-chair), Dr. Elliot M. Landaw, and Dr. Julian A. Martinez.
Elliot has been reappointed to another term (2009-2014) as Chair of UCLA Biomathematics. Interests: Identifi ability and optimal experiment design for compartmental models; nonlinear regression; modeling/estimation applications in pharmacokinetics, ligand-receptor analysis, transport, and molecular biology.
Tom has been promoted to full professor as of July 2009. Tom earned his Ph.D. in Physics from Harvard University (1995). He joined our faculty in July 2000. Interests: Applied mathematics, theoretical biophysics, cellular and molecular modeling, stochastic processes.
Along with Principal Co-Investigator Dr. Donald Tashkin (Medicine) awarded $10.466 million grant (5 years) for a multi-site study testing whether mycophenolate mofetil is safer and more effective than oral cyclophosphamide in treating schleroderma-realted interstitial lung disease, and to develop a database, data management and analysis. Interests: Markov renewal models in survival analysis, random coeffi cient regression models, adaptive designs.
The Department welcomed Assistant Professor Van Savage to our Department in January 2009. He is the department’s first primary appointee since 2000. His research focuses on models of vascular networks with physiological and biomedical applications, and he also develops models to help understand how diversity is constrained and organized in biological systems. In particular his work addresses questions about vascular networks in plants and animals, how tumors develop their own vasculature and how this affects their growth rate, predictions for sleep times across species and during development, and how physiology and the environment affect species interactions. In addition, Van is currently developing a trait-based framework that tracks the fl uctuations in multiple, correlated environmental drivers and how these affect biomass distributions, and he is helping to construct new models for timescales involved in speciation-extinction dynamics. Van was an undergraduate at Rhodes College in Memphis, Tennessee where he majored in Physics and minored in Mathematics. He did his graduate work at Washington University in St. Louis with Carl Bender and Claude Bernard on analytical and numerical techniques for studying PT-symmetric but non-Hermitian Hamiltonians. During his last year of graduate school, Van was awarded a six-month NSF fellowship to do research at the Santa Fe Institute. While there, Van began his interests in biological problems by studying allometric relationships-how biological rates and times, such as metabolic rate and lifespan, depend on body size and body temperature across species. Before joining the Biomathematics faculty, Van was a postdoctoral fellow at the Santa Fe Institute and Los Alamos National Laboratory (advisors Geoffrey West and James Brown), a Systems Biology postdoctoral fellow at Harvard University, and an Instructor at Harvard Medical School.
We are pleased to announce that a fund has been established in the UCLA Department of Biomathematics for student support in honor of Dr. Carol. M. Newton. Dr. Newton has been and continues to be a a pioneer, teacher, and role model for generations of biomathematicians. Her vision has encouraged us all to take an interdisciplinary modeling focus and helped us to make contributions to biomedical research. The Carol M. Newton Fund will be a meaningful tribute to her and to the Biomathematics graduate program. The fund will be used for student support, with a special emphasis on student travel awards. This emphasis reflects Dr Newton’s firm belief that travel and exposure to other institutions and cultures is an important component in every biomathematician’s education. Our ultimate goal is to raise enough for an endowment, which provides income from the principal in perpetuity.
Professor Emeritus Wilfrid Dixon, passed away on September 20, 2008. Dr. Dixon received his B.A. from Oregon State College (Mathematics) in 1938, followed by his M.A. from the University of Wisconsin in 1939, and earned his Ph.D. in Mathematical Statistics from Princeton in 1944. Dr. Dixon was the founder and Chair (1967-1974) of the UCLA Biomathematics Department. During his long and productive career at UCLA (1955-1986), he developed the BMD and BMDP Statistical Software packages that became industry standards long before the likes of SAS or SPSS.
We are very pleased that Dr. Steven Piantadosi has joined our faculty. Steve earned his M.D. from the University of North Carolina and his doctorate in Biomathematics from the University of Alabama Birmingham. He is the currently Director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. Prior to joining Cedars-Sinai in April 2007, Steve was Professor of Oncology at The Johns Hopkins School of Medicine and Director of Biostatistics at the Sidney Kimmel Comprehensive Cancer as well as holding joint appointments in Biostatistics and Epidemiology in their school of public health. A world renowned researcher in the development of methodology for the design and analysis of clinical trials, Steve’s appointment augments the Department’s existing strength in this area provided by Prof. Robert Elashoff. In addition to advising both FDA and industry, he is a regular advisor for the NIH and other prominent cancer programs and centers. As author of more than 230 peer-reviewed scientifi c articles, Steve currently serves as senior editor of the journal Clinical Cancer Research. His appointment is a great plus for the Department’s Masters in Clinical Research program that provides training to clinicians who are interested in translational research. He has already taught Biomathematics M260A, “Methodology in Clinical Research”, an integral part of this program.
Named Chief Scientific Officer of Theranos, Inc. in Palo Alto. Seth Michelson is a Biomathematician with over twenty years experience in modeling and simulating biological systems with more than 80 publications in the peer-reviewed literature. Before joining Theranos, Dr. Michelson was VP, In Silico R&D at Entelos, Inc. a modeling and simulation company in Foster City, California.